There are 2789 resources available
1070P - Adjuvant treatment for melanoma in clinical practice: Trial versus reality
Presenter: Melissa De Meza
Session: ePoster Display
1071P - A nationwide, real-life study of outcome and quality of life after the introduction of adjuvant immunotherapy for Danish melanoma patients
Presenter: Eva Ellebaek
Session: ePoster Display
1072P - Primary ipilimumab/nivolumab immunotherapy followed by adjuvant nivolumab in patients with locally advanced or oligometastatic melanoma: Update on outcome
Presenter: Emilia Cocorocchio
Session: ePoster Display
1073P - Quality of life (QOL) endpoints from the phase III intergroup S1404 adjuvant melanoma trial
Presenter: Sapna Patel
Session: ePoster Display
1074P - Italian nivolumab Expanded Access Program (EAP) in melanoma adjuvant setting: Patients outcomes and safety profile
Presenter: Michele Del Vecchio
Session: ePoster Display
891P - Landscape of NOTCH1 genomic alterations (GA) in head and neck squamous cell carcinoma (HNSCC) and T-ALL
Presenter: Kristian Ikenberg
Session: ePoster Display
892P - The genomic features of Chinese oropharyngeal squamous cell carcinomas and the implications for therapy
Presenter: QUNXING LI
Session: ePoster Display
893P - Clinico-genetic profiling of HRAS mutant head and neck squamous cell carcinoma (HNSCC)
Presenter: Xiuning Le
Session: ePoster Display
894P - Investigation of ARID1A mutation and correlation with immunotherapy biomarker in Chinese head and neck cancer patients
Presenter: Jianming gao
Session: ePoster Display